basic
structur
femal
reproduct
system
ovari
fallopian
tube
uteru
cervix
vagina
ovari
respons
product
ovum
secret
estrogen
progesteron
ovum
develop
ovari
encapsul
sac
known
ovarian
follicl
matur
ovum
follicl
ovari
wall
ruptur
allow
ovum
escap
enter
fallopian
tube
reach
uteru
uteru
muscular
organ
use
accept
fertil
ovum
becom
implant
endometrium
cervix
neck
uteru
protrud
upper
anterior
vagin
wall
vagina
fibromuscular
canal
connect
upper
part
femal
genit
tract
outsid
bodi
repres
portal
entri
pathogen
microorgan
epitheli
mucosa
lower
genit
tract
extens
colon
commens
microorgan
tissu
upper
genit
tract
gener
consid
steril
howev
bacteri
colon
upper
genit
tract
healthi
asymptomat
women
remain
somehow
controversi
issu
vagin
tract
colon
microorgan
recogn
vagin
microbiota
vm
microorgan
addit
complex
synerg
among
secret
protein
peptid
epitheli
immun
cell
perform
pivot
role
defens
femal
genit
tract
infecti
inflammatori
process
state
mucos
health
variou
compon
balanc
ruptur
mucos
homeostasi
determin
alter
one
variou
actor
often
result
increas
host
suscept
infect
healthi
vm
domin
lactobacillu
spp
microorgan
present
lesser
extent
gardnerella
prevotella
streptococcu
ureaplasma
peptostreptococcu
staphylococcu
corynebacterium
clostridium
mycoplasma
enterococcu
bacteroid
escherichia
bifidobacterium
veillonella
candida
speci
lactobacillu
detect
vagina
howev
major
women
healthi
vagin
microflora
contain
one
two
lactobacillu
speci
among
lactobacillu
crispatu
lactobacillu
gasseri
lactobacillu
jensenii
lactobacillu
iner
current
role
l
iner
vagin
health
still
unclear
inde
l
iner
recent
detect
dysbiot
healthi
women
presenc
amount
invers
correl
l
crispatu
lactobacilli
involv
maintain
healthi
vagin
environ
counteract
overgrowth
resid
microorgan
lactobacilli
also
colon
human
cervix
differ
studi
rang
women
result
colon
lactobacilli
cervix
within
singl
subject
usual
lactobacillu
strain
colon
cervix
vagin
tract
lactobacilli
exert
protect
effect
sever
mechan
microbi
competit
nutrient
adher
vagin
epithelium
ii
reduct
vagin
ph
product
organ
acid
especi
lactic
acid
degrad
glycogen
releas
vagin
cell
thu
exert
select
antimicrobi
activ
nonresid
microbiota
iii
product
antimicrobi
substanc
bacteriocin
hydrogen
peroxid
abl
suppress
growth
sever
microorgan
iv
modul
local
immun
system
homeostasi
vagin
environ
result
complex
interact
synergi
among
host
differ
microorgan
colon
vagin
mucosa
mainten
high
number
resid
lactobacilli
effect
hallmark
woman
health
wellorgan
protect
pathogen
caus
sexual
tranmit
infect
sti
abnorm
vm
involv
strong
reduct
disappear
lactobacilli
character
patholog
condit
known
bacteri
vaginosi
bv
afflict
fertil
premenopaus
pregnant
women
incid
rate
rang
bv
polymicrobi
clinic
syndrom
result
replac
normal
lactobacillu
spp
high
number
anaerob
bacteria
gardnerella
vaginali
prevotella
spp
mobiluncu
spp
ureaplasma
mycoplasma
fastidi
cultur
anaerob
bv
overgrow
anaerob
produc
compound
polyamin
molecul
capabl
induc
releas
proinflammatori
cytokin
bv
repres
independ
risk
factor
sever
reproduct
tract
sequela
associ
pelvic
inflammatori
diseas
tubal
factor
infertil
chang
vm
also
associ
obstetr
complic
late
miscarriag
prematur
birth
thu
exert
profound
impact
also
health
newborn
moreov
women
lactobacillu
poor
flora
show
increas
suscept
sexual
transmit
pathogen
sever
studi
indic
abnorm
vm
lack
lactobacilli
associ
acquisit
infect
neisseria
gonorrhoea
chlamydia
trachomati
trichomona
vaginali
furthermor
alter
vm
associ
increas
risk
acquir
viral
sexual
transmit
diseas
std
inde
longitudin
crosssect
studi
demonstr
associ
alter
vm
increas
prevalenceincid
mani
viral
sti
human
immunodefici
viru
hiv
herp
simplex
viru
hsv
human
papillomaviru
cytomegaloviru
infect
addit
lactobacilli
cervicovagin
fluid
cvf
exert
signific
microbicid
activ
gramposit
gramneg
bacteria
fungi
certain
virus
well
antiinflammatori
activ
sever
peptid
protein
character
common
cation
featur
main
antimicrobi
peptid
protein
present
cvf
shown
tabl
peptid
protein
act
differ
mechan
microbi
lysi
ii
deplet
environment
nutrient
essenti
microbi
growth
iii
competit
bind
host
cell
iv
degrad
neg
charg
microbi
surfac
compon
v
interfer
host
cell
signal
pathway
vi
modul
inflamm
function
involv
host
defens
bactericid
activ
mani
compound
strictli
associ
cation
featur
concentr
molecul
cvf
lower
requir
vitro
inhibit
pathogen
howev
known
sever
antimicrobi
display
synergist
effect
inde
human
defensin
cathelicidin
antimicrobi
peptid
secretori
leukocyt
proteas
inhibitor
slpi
lysozym
lactoferrin
lf
lysozym
display
synergist
effect
potenti
increas
innat
immun
protect
femal
reproduct
tract
mani
antimicrobialimmunomodulatori
compound
appear
hormon
control
cvf
defensin
slpi
lysozym
level
high
prolif
phase
greatli
decreas
midcycleovul
increas
late
secretori
phase
lactoferrin
belong
transferrin
famili
multifunct
glycoprotein
amino
acid
mw
kda
lf
chelat
two
fe
iii
per
molecul
high
affin
kd
low
ph
characterist
infect
site
lf
abundantli
found
biolog
fluid
mammal
synthes
exocrin
gland
mani
mucos
epitheli
cell
releas
neutrophil
inflamm
highest
level
human
lf
hlf
found
colostrum
mgml
decreas
matur
milk
mgml
tear
hlf
detect
low
concentr
mgml
saliva
small
intestin
earwax
vagin
fluid
amniot
fluid
upper
airway
fluid
semin
plasma
cervic
mucu
low
level
mgml
particular
concentr
hlf
human
vagin
fluid
correspond
extrem
high
cervic
mucu
plug
note
total
number
neutrophil
releas
hlf
site
inflamm
infect
human
bodi
fluid
concentr
free
avail
iron
must
overcom
avoid
microbi
multipl
hinder
precipit
insolubl
ferric
hydroxid
well
format
reactiv
oxygen
speci
hlf
ironbind
abil
guarante
free
avail
iron
exceed
hlf
bovin
milk
deriv
lf
blf
possess
high
homolog
sequenc
threedimension
structur
lf
fold
two
homolog
lobe
structur
two
domain
one
fe
iii
ion
chelat
lobe
lf
complet
iron
satur
conform
appear
close
state
resist
proteolyt
enzym
unsatur
open
form
low
iron
avail
hinder
microbi
growth
signal
health
well
iron
concentr
higher
favor
microbi
replic
also
biofilm
format
persist
interestingli
wiesner
vilcinska
report
protein
peptid
mucos
secret
possess
sever
function
accordingli
hlf
blf
multifunct
glycoprotein
effect
bacteria
mycet
virus
parasit
possess
also
antiinflammatori
immunomodulatori
properti
particular
blf
avail
larg
quantiti
recogn
food
drug
administr
fda
usa
safe
substanc
main
lf
use
vitro
studi
well
clinic
trial
mice
level
vagin
hlf
other
antimicrobi
peptid
chang
respons
microbi
infect
demonstr
hlf
defensin
level
increas
genit
secret
women
c
trachomati
n
gonorrhoea
vaginali
candida
spp
infect
bv
comparison
healthi
condit
innat
defens
system
femal
mucos
genit
tract
involv
complex
interact
among
healthi
vagin
flora
immun
cell
sever
protein
defend
host
pathogen
broadli
suggest
crucial
role
vagin
lactobacilli
protect
femal
genit
tract
product
lactic
acid
respons
low
vagin
ph
inhibit
sexual
transmit
pathogen
lactic
acid
equilibrium
lactat
anion
former
predomin
form
healthi
vagin
condit
low
ph
thu
exert
antimicrobi
activ
pathogen
lactat
anion
predomin
higher
ph
condit
women
dysbiosi
vitro
experi
demonstr
physiolog
concentr
mm
lactic
acid
ph
bvassoci
bacteria
g
vaginali
atopobium
vagina
inactiv
without
effect
typic
vagin
speci
lactobacilli
furthermor
inactiv
bvassoci
speci
depend
lactic
acid
rather
ph
sinc
ph
valu
determin
acid
significantli
less
microbicid
recent
vitro
studi
howev
demonstr
c
trachomati
multipl
inhibit
differ
strain
vagin
lactobacilli
independ
ph
alter
c
trachomati
oblig
intracellular
pathogen
respons
common
bacteri
std
worldwid
caus
acut
chronic
infect
unlik
acut
infect
cure
oral
topic
administr
antibiot
chronic
infect
difficult
erad
need
prolong
therapi
thu
increas
risk
develop
antibiot
resist
therefor
novel
altern
therapi
need
difficulti
find
new
agent
c
trachomati
infect
resid
complex
life
cycl
peculiar
pathogen
fact
c
trachomati
uniqu
biphas
development
cycl
altern
extracellular
infecti
elementari
bodi
eb
metabol
inact
intracellular
noninfecti
reticular
bodi
rb
metabol
activ
recent
demonstr
vagin
lactobacilli
inhibit
eb
adhes
epitheli
cell
well
intracellular
rb
replic
effect
earli
phase
infect
relat
coaggreg
lactobacilli
c
trachomati
competit
epitheli
cell
adhes
inhibit
chlamydi
infect
lactobacilli
strain
dose
depend
suggest
strain
amount
lactobacilli
vagina
respons
protect
chlamydi
infect
lactobacilli
demonstr
protect
lower
femal
genit
tract
also
n
gonorrhoea
infect
second
common
bacteri
sti
interact
bacteria
host
cell
determin
success
pathogen
mucos
colon
elimin
continu
fluid
flow
respect
vielfort
et
al
show
lactobacilli
compet
n
gonorrhoea
adhes
human
cervic
cell
also
demonstr
l
jensenii
atcc
could
reduc
adhes
invas
n
gonorrhoea
wherea
l
gasseri
atcc
could
displac
adher
gonococci
cell
surfac
protect
exert
healthi
vm
toward
viral
infect
ascrib
direct
virucid
effect
mainten
natur
defens
factor
present
vagin
milieu
mechan
suggest
result
obtain
vitro
experi
clinic
observ
infect
women
lactobacillu
metabolit
possess
antimicrobi
activ
may
directli
protect
viral
infect
hydrogen
peroxid
produc
lactobacilli
play
import
role
natur
microbicid
within
vagin
ecosystem
due
toxic
activ
number
microorganim
virus
includ
observ
rang
lactobacilli
present
vagin
flora
healthi
women
produc
percentag
drop
women
affect
vagin
infect
physiolog
acid
vagin
ph
valu
determin
lactobacilli
inactiv
hiv
addit
inactiv
lactic
acid
concentr
lead
ph
valu
similar
one
detect
healthi
human
vagina
sever
compound
releas
lactobacilli
impair
effici
target
cell
support
viral
replic
nonprotein
cell
wall
compon
extract
vagin
strain
lactobacillu
brevi
strongli
reduc
replic
cell
cultur
wherea
acid
lactobacillu
metabol
product
decreas
activ
lymphocyt
consequ
lower
lymphocyt
suscept
infect
healthi
vm
contribut
mainten
natur
defens
mechan
invad
pathogen
gel
layer
coat
vagin
cervic
mucosa
repres
physic
barrier
hinder
viral
bind
cell
membran
receptor
thu
protect
women
viral
infect
inde
vitro
studi
demonstr
hsv
could
trap
viscou
cervic
mucu
bvrelat
microorgan
abl
produc
higher
level
mucindegrad
enzym
mucinas
sialidas
comparison
lactobacillidomin
healthi
vagin
flora
therefor
increas
degrad
protect
mucu
layer
may
promot
bind
virus
underli
epitheli
cell
receptor
studi
demonstr
vagin
lactobacilli
abl
inhibit
first
step
infect
cell
cultur
antivir
activ
exert
presenc
lactobacilli
bind
cell
membran
strain
depend
appear
directli
relat
adhes
capac
lactobacillu
strain
conclus
sever
mechan
may
involv
antimicrobi
effect
vagin
lactobacilli
interfer
microorgan
process
adhes
entri
host
cell
product
metabolit
direct
antimicrobi
effect
product
compound
abl
inhibit
oblig
intracellular
pathogen
replic
contribut
mainten
natur
defens
factor
present
vagin
milieu
alreadi
discuss
hlf
one
import
defens
protein
cvf
fact
endogen
hlf
found
increas
genit
fluid
women
affect
neisseria
gonorrhea
c
trachomati
vaginali
infect
andor
vagin
dysbiosi
respect
hlf
releas
neutrophil
recruit
situ
could
repres
marker
nonhealthi
condit
one
mediat
involv
counteract
inflammatori
mileu
first
function
hlf
recogn
vitro
bacteriostat
activ
depend
abil
sequest
iron
necessari
bacteri
surviv
growth
hlf
blf
establish
battl
iron
acquisit
pathogen
capabl
counteract
ironbind
protein
synthes
siderophor
small
high
affin
ironchel
molecul
iron
acquisit
sourc
matter
fact
g
vaginali
lack
siderophor
acquir
iron
lysi
erythrocyt
use
hemoglobin
iron
sourc
consist
observ
g
vaginali
level
increas
mens
moreov
independ
ironbind
abil
blf
exert
sever
antibacteri
activ
bacteri
lysi
bind
lipopolysaccharid
lp
ii
inhibit
bacteri
adhes
epitheli
cell
iii
inhibit
entri
host
cell
facult
oblig
intracellular
bacteria
competit
bind
host
cell
andor
microbi
surfac
compon
refer
therein
note
facult
intracellular
pathogen
requir
intracellular
nutrient
includ
iron
replic
mammalian
cell
oblig
intracellular
c
trachomati
except
prepar
blf
iron
satur
consent
iron
chelat
util
vitro
model
check
antichlamydi
activ
similar
observ
use
vagin
lactobacilli
incub
cell
monolay
blf
infect
moment
infect
significantli
inhibit
adhes
entri
c
trachomati
epitheli
cell
therefor
inhibit
c
trachomati
infect
blf
depend
interact
cell
surfac
especi
glycosaminoglycan
heparan
sulfat
proteoglycan
potenti
receptor
c
trachomati
adhes
convers
preincub
blf
c
trachomati
eb
influenc
infect
support
idea
specif
interact
blf
epitheli
host
cell
could
sole
mechan
respons
inhibit
c
trachomati
invas
recent
inhibit
synthesi
blf
demonstr
vitro
model
mimick
vivo
chlamydi
infect
blf
ad
infect
cell
h
postinfect
produc
signific
decreas
without
effect
number
intracellular
chlamydia
similarli
level
reduc
blf
ad
h
postinfect
epitheli
monolay
infect
facult
intracellular
bacteria
lpsstimul
macrophag
antichlamydi
activ
blf
relat
antiinflammatori
function
shown
vivo
pilot
studi
pregnant
women
show
cervic
specimen
posit
c
trachomati
treat
intravagin
administr
blf
mg
everi
h
day
interestingli
month
six
women
result
neg
c
trachomati
show
signific
decreas
level
cvf
similar
observ
vitro
model
intravagin
administr
blf
seem
act
protect
mucos
host
cell
adhes
entri
chlamydi
eb
releas
extracellularli
redifferenti
rb
eb
decreas
level
could
marker
inhibit
c
trachomati
eb
infect
host
cell
due
presenc
blf
word
blf
protect
host
cell
prevent
earli
phase
infect
eb
unlik
lactobacilli
blf
affect
replic
rb
potenti
influenc
exogen
blf
microbi
commun
popul
vagina
recent
investig
vagin
blf
administr
women
bv
shown
abl
modifi
vm
composit
fact
treatment
induc
reduct
bvassoci
gardnerella
prevotella
lachnospira
genera
well
increas
lactobacillu
speci
data
suggest
therapeut
potenti
blf
counteract
femal
genit
tract
diseas
inde
would
relev
unveil
molecular
mechan
well
immunolog
chang
accompani
blf
effect
microbiota
furthermor
blf
antivir
activ
verifi
envelop
nake
virus
exert
earli
stage
infect
thu
inhibit
viral
bind
entri
host
cell
activ
mainli
due
blf
bind
heparan
sulfat
glycosaminoglycan
cell
receptor
viral
particl
similar
viral
particl
inhibit
plasmodium
endocytosi
attribut
interact
blf
cell
surfac
heparan
sulfat
lipoprotein
receptorrel
protein
respect
blf
repres
relev
protein
symbol
brick
wall
natur
nonimmun
defens
human
mucos
fluid
microbi
infect
well
known
lactobacilli
endow
healthpromot
immunomodulatori
properti
along
bifidobacteria
propos
candid
prevent
andor
treatment
allergi
coliti
infect
inflammatori
condit
lactobacillu
strain
also
propos
vagin
microbicid
candid
sti
eg
n
gonorrhoea
candida
albican
hiv
besid
mechan
relat
bacterium
eg
enhanc
epitheli
barrier
function
competit
pathogen
capabl
redirect
immun
respons
underli
mani
benefici
effect
lactobacilli
vitro
data
demonstr
l
crispatu
l
jensenii
act
colon
epitheli
cell
also
influenc
cytokin
secret
pattern
particular
upon
recognit
tolllik
receptor
tlr
signal
activ
without
induct
proinflammatori
mediat
furthermor
secret
cytokin
inhibit
product
defensin
induc
ensur
homeostasi
immun
respons
although
innat
immun
first
level
influenc
probiot
interact
mucos
epithelium
cell
eg
dendrit
cell
shape
lactobacilli
skew
adapt
respons
exampl
repres
l
crispatu
strain
shown
confer
antiinflammatori
properti
dendrit
cell
induc
upregul
product
induct
regulatori
cell
mention
key
metabolit
produc
lactobacilli
lactic
acid
besid
antimicrobi
properti
mani
immun
modul
mechan
exert
lactobacilli
ascrib
compound
particular
lactic
acid
shown
induc
antiinflammatori
respons
vagin
cervic
epitheli
cell
inhibit
rant
secret
stimul
tlr
agonist
use
mimic
pathogenassoci
molecular
pattern
pamp
microb
given
known
promot
replic
hiv
activ
transcript
hiv
target
cell
lactic
acid
produc
lactobacilli
vagin
environ
could
relev
context
viral
infect
acquisit
furthermor
antiinflammatori
cytokin
induc
lactic
acid
treatment
cervicovagin
epitheli
cell
antiinflammatori
effect
mediat
l
dlactic
acid
isom
proton
form
predomin
healthi
condit
low
valu
vagin
ph
data
immunolog
chang
associ
benefit
induc
lactobacilli
administr
avail
vagin
tract
vivo
physiolog
patholog
condit
lactobacillu
salivariu
crl
l
gasseri
crl
propos
good
candid
keep
balanc
microbiota
immun
surveil
inde
murin
model
set
evalu
benefit
lactobacilli
effect
mous
vagin
mucosa
innat
immun
cell
lactobacilli
inocul
modifi
amount
granulocyt
macrophag
vagin
wash
human
shown
administr
probiot
lactobacillu
vagin
tablet
produc
signific
reduct
level
vagin
cytokin
demonstr
capac
lactobacilli
modul
product
inflammatori
cytokin
women
bv
women
healthi
vagin
flora
link
oral
probiot
administr
vmimmun
marker
recent
demonstr
vitali
et
al
pregnant
women
author
investig
effect
dietari
supplement
vsl
probiot
mixtur
contain
eight
speci
lactobacillu
bifidobacterium
streptococcu
vm
late
pregnanc
interestingli
chang
bacteri
count
repres
popul
reveal
upon
probiot
administr
howev
probiot
mixtur
abl
chang
composit
less
abund
vagin
microorgan
avoid
reduct
bifidobacterium
increas
atopobium
record
last
trimest
pregnanc
control
healthi
women
signific
modif
local
immun
system
also
associ
consumpt
probiot
show
antiinflammatori
effect
particular
vagin
level
maintain
balanc
compar
reduct
observ
control
group
furthermor
vagin
level
eotaxin
proinflammatori
chemokin
reduc
upon
probiot
dietari
supplement
similar
lactobacilli
also
blf
exhibit
effect
host
immun
system
rang
inhibit
inflamm
promot
innat
adapt
immun
respons
innat
immun
shape
endogen
hlf
interact
pamp
andor
pattern
recognit
receptor
prr
express
host
cell
vitro
studi
demonstr
carbohydr
chain
hlf
make
abl
interact
directli
result
moder
activ
associ
pathway
lp
typic
pamp
bound
hlf
result
inhibit
cell
activ
inflammatori
respons
propos
vivo
hlf
inhibit
lpsstimul
signal
depress
endotoxemia
particular
upon
lp
bind
hlf
act
reduc
product
immun
cell
macrophag
neutrophil
lymphocyt
well
releas
endotheli
cell
demonstr
level
hlf
increas
inflammatori
diseas
rheumatoid
arthriti
sever
acut
respiratori
syndrom
inflammatori
bowel
diseas
mention
std
bv
observ
suggest
hlf
could
use
clinic
marker
inflammatori
condit
besid
prr
pamp
bind
hlf
displac
proteas
heparin
mast
cell
thu
play
antiallerg
effect
furthermor
hlf
compet
bind
proteoglycan
endothelium
thu
interf
neutrophil
recruit
site
inflamm
hlf
shown
bind
also
dna
neutrophil
extracellular
trap
net
capabl
play
key
role
context
netosi
net
product
neutrophil
hlf
adher
dna
structur
releas
due
chromatin
decondens
spread
exert
antimicrobi
properti
vitro
experi
show
recombin
hlf
abl
induc
matur
antigenpres
cell
dendrit
cell
thu
suggest
repres
link
shape
adapt
immun
depend
extern
stimulu
pathogen
allergen
tumor
antigen
etc
host
immun
statu
hlf
modul
level
thu
provid
differ
outcom
strong
polar
infect
tumor
reduct
excess
respons
correct
balanc
allergi
autoimmun
furthermor
lf
abl
support
prolifer
cell
precursor
differenti
besid
role
cellularmedi
immun
hlf
influenc
activ
b
cell
thu
play
role
also
humor
respons
effect
exogen
lf
immun
respons
evalu
differ
vitro
system
differ
epitheli
cell
monolay
infect
variou
facult
oblig
intracellular
pathogen
produc
proinflammatori
cytokin
addit
blf
significantli
decreas
nfkb
level
result
obtain
differ
vitro
model
variou
clinic
trial
confirm
blf
abil
downregul
proinflammatori
cytokin
synthesi
demonstr
exogen
blf
local
cell
nucleu
thu
act
transcript
factor
inhibit
proinflammatori
cytokin
although
mechan
blf
exert
antiinflammatori
activ
still
debat
recent
blf
abil
decreas
high
level
cvf
seem
strictli
relat
capac
restor
iron
homeostasi
disord
therefor
lf
key
element
host
defens
system
also
pivot
compon
abl
regul
inflammatori
respons
iron
homeostasi
recent
blf
emerg
attract
molecul
treat
inflamm
rang
proinflammatori
macrophag
phenotyp
regulatoryantiinflammatori
phenotyp
defens
femal
mucos
genit
tract
larg
influenc
hormon
paracrin
product
variou
cytokin
vagin
environ
undergo
overtim
shift
represent
abund
microbi
key
speci
influenc
factor
may
includ
age
hormon
fluctuat
sexual
activ
use
medic
hygien
vagina
line
stratifi
keratin
squamou
epithelium
variabl
thick
structur
depend
life
stage
vagin
epithelium
consist
three
cell
layer
superfici
intermedi
basal
capabl
store
glycogen
influenc
estrogen
prepubert
postmenopaus
women
epithelium
thin
character
basal
layer
cell
sever
layer
parabas
cell
thin
atroph
epithelium
suscept
infect
frequent
show
degen
inflammatori
chang
vagin
epithelium
reflect
hormon
chang
menstrual
cycl
increas
mitosi
basal
layer
influenc
estrogen
prolif
phase
cycl
whole
epithelium
thicken
multilay
secretori
phase
cycl
intermedi
layer
becom
thick
cell
stuf
glycogen
therefor
glycogen
content
vagin
epithelium
covari
estrogen
level
breakdown
glycogen
resid
healthi
vm
produc
acid
ph
vagina
deter
infect
inde
reproductiveag
women
carri
lactobacillu
speci
predomin
lactic
acid
bacteria
genera
streptococcu
atopobium
conserv
ecolog
function
lactat
product
vagin
microbiom
well
demonstr
fluctuat
vm
occur
base
intercours
infect
also
menstrual
cycl
gener
high
level
estradiol
may
favor
lactobacillidomin
environ
especi
l
crispatu
l
gasseri
andor
l
jensenii
underrepres
low
estrogen
condit
begin
menstrual
cycl
postmenopaus
women
one
studi
l
crispatu
appear
declin
mens
g
vaginali
increas
along
l
iner
subsequ
concentr
speci
decreas
mens
studi
l
crispatu
also
report
declin
mens
number
l
iner
strongli
increas
recent
cultivationindepend
method
highlight
complex
tempor
variabl
vm
particular
gajer
et
al
describ
tempor
chang
composit
vm
reproductiveag
women
within
period
gener
highest
variabl
microbiota
commun
associ
mens
exampl
subject
show
commun
domin
l
crispatu
could
replac
l
iner
mens
streptococcu
spp
differ
subject
commun
could
revert
commun
domin
l
crispatu
end
mens
moreov
result
also
show
bacteri
commun
chang
greatli
short
time
period
other
stabl
hormon
level
combin
divers
data
show
increas
estradiol
progesteron
correspond
decreas
microbi
variabl
vagin
metabolom
data
ad
inform
commun
function
maintain
despit
chang
composit
inde
shift
commun
composit
involv
chang
rel
domin
littl
number
differ
bacteria
abl
produc
lactic
acid
interestingli
recent
studi
perform
investig
time
sequenc
chang
occur
vagin
vulvar
microbiota
puberti
show
vm
perimenarch
girl
resembl
reproductiveag
women
fact
l
crispatu
l
iner
l
gasseri
l
jensenii
subject
streptococcu
spp
domin
microbiota
girl
onset
menarch
earli
middl
stage
puberti
studi
perform
increas
knowledg
link
estrogen
vagin
glycogen
level
lactic
acid
bacteria
abund
vagin
ph
import
fluctuat
vagin
microbiom
record
pregnanc
aagaard
et
al
show
microbiom
enrich
l
iner
l
crispatu
l
jensenii
l
johnsonii
increas
lactobacilli
may
due
increas
estrogen
level
occur
pregnanc
although
investig
need
better
understand
relationship
specif
speci
lactobacillu
estrogen
level
howev
anoth
studi
show
l
crispatu
l
iner
domin
vagin
flora
pregnanc
progress
matern
age
seem
import
domin
l
crispatu
l
iner
l
iner
domin
older
gravida
mention
menopaus
usual
repres
phase
lactobacilli
level
low
seem
implic
even
pronounc
involv
featur
actual
invers
correl
found
lactobacillu
level
vagin
dryness
common
condit
postmenopaus
period
shown
associ
chang
vagin
epitheli
cell
integr
inflamm
besid
endogen
hormon
fluctuat
clinic
evid
demonstr
use
hormon
contracept
also
abl
induc
chang
vm
thu
influenc
suscept
sti
bv
therefor
sti
bv
turn
predispos
sti
depend
part
modif
vagin
bacteri
commun
induc
contracept
method
clinic
trial
base
nugent
score
endpoint
questionnair
reveal
reduc
bv
rate
women
use
estrogencontain
contracept
effect
progestincontain
contracept
depot
medroxyprogesteron
acet
dmpa
levonorgestrel
less
clear
systemat
review
elig
studi
author
shown
combin
oral
contracept
coc
combin
estrogen
progestin
dmpa
reduc
bv
rang
respect
accordingli
recent
retrospect
studi
fertil
women
base
rrna
sequenc
author
found
women
use
coc
dmpa
show
reduc
colon
bvassoci
bacteria
compar
women
use
condom
studi
women
use
progestinbas
therapi
significantli
higher
abund
taxa
associ
dysbiot
vm
hand
coc
user
lactobacillidomin
vm
higher
proport
lactobacillu
speci
l
crispatu
l
gasseri
l
jensenii
correl
vagin
health
compar
progestincontain
contracept
differ
result
report
studi
reveal
chang
vagin
bacteri
commun
associ
progestin
use
could
due
differ
studi
popul
characterist
eg
ethnic
subject
andor
design
studi
specif
bv
statu
examin
women
bv
vm
level
hormon
contracept
act
fact
chang
genit
tract
immun
effect
hormon
contracept
shown
term
suppress
activ
respons
studi
women
cervic
secret
contain
lower
level
proinflammatori
molecul
tnf
gmcsf
subject
bv
use
hormon
contracept
compar
use
hand
increas
inflammatori
cytokin
rant
associ
hormon
contracept
differ
crosssect
analysi
includ
african
women
conflict
data
exist
studi
immunomodulatori
potenti
hormon
contracept
femal
genit
tract
complic
variabl
term
vitro
versu
vivo
model
use
sampl
test
plasma
blood
versu
cervic
fluid
howev
investig
featur
may
repres
key
point
understand
associ
hormon
contracept
hiv
acquisit
fact
women
use
progestin
dmpa
use
coc
found
significantli
increas
risk
hiv
infect
compar
women
use
hormon
contracept
recent
select
specimen
larg
prospect
clinic
studi
author
investig
innat
immun
mediat
cervic
sampl
collect
women
visit
hiv
seroconvers
match
visit
women
remain
hiv
uninfect
higher
level
proinflammatori
marker
rant
found
hiv
seroconvers
dmpa
user
suggest
possibl
role
cytokin
associ
contracept
hiv
risk
acquisit
possibl
explan
could
upregul
rant
observ
women
use
dmpa
women
bv
may
simultan
block
cellular
hiv
receptor
also
facilit
transmiss
recruiment
target
cell
also
sti
influenc
hormon
contracept
candidiasi
found
increas
women
use
coc
dmpa
taken
togeth
observ
suggest
alter
immun
respons
effect
hormon
contracept
may
predispos
infect
pathogen
case
preexist
condit
dysbiosi
specif
cervicovagin
infect
suppress
activ
immun
pathogen
could
increas
risk
infect
cumul
action
exogen
hormon
similar
estrogeninduc
chang
speci
number
lactobacilli
hlf
concentr
fluctuat
accordingli
circul
estrogen
level
addit
hlf
level
produc
uterin
epithelium
releas
cvf
synthesi
iga
igg
also
modul
estrogen
progesteron
thu
exert
immun
protect
sexual
transmit
pathogen
figur
show
comparison
among
estrogen
progesteron
lf
level
prolif
ovulatori
secretori
phase
hlf
level
increas
line
estrogen
product
reach
highest
level
ovulatori
phase
invers
correl
progesteron
level
matter
fact
secretori
phase
accordingli
increas
progesteron
show
lowest
level
hlf
end
secretori
phase
hlf
return
increas
parallel
progesteron
decreas
obvious
use
oral
contracept
decreas
estrogen
synthesi
suppress
product
hlf
well
immunoglobulin
durat
hormon
exposur
thu
possibl
increas
suscept
women
infect
rat
pretreat
progesteron
prior
exposur
chlamydia
thracomati
infect
induc
persist
infect
furthermor
rat
treat
progesteron
also
found
vulner
chlamydi
intrauterin
infect
wherea
treatment
estradiol
major
femal
estrogen
sex
hormon
reduc
suscept
infect
sex
steroid
hormon
also
import
mediat
inflamm
may
influenc
resist
suscept
parasit
infect
sex
steroid
hormon
also
involv
viral
infect
propos
util
window
vulner
menstrual
cycl
crucial
period
overlap
midcycl
innat
adapt
immun
respons
suppress
estrogen
andor
progesteron
facilit
reproduct
process
presum
exploit
time
frame
antivir
factor
suppress
establish
propag
infect
femal
mucos
genit
tract
menopaus
women
low
concentr
hlf
secret
relat
low
level
sexual
hormon
may
lead
recurr
infect
import
underlin
mens
decreas
import
natur
defens
glycoprotein
balanc
presenc
neutrophil
synthesi
granul
restor
least
partial
hlf
concentr
antimicrobi
activ
epitheli
barrier
disrupt
recruit
neutrophil
occur
high
level
inflammatori
biomark
proinflammatori
cytokin
creactiv
protein
matter
fact
menstruat
well
age
menopaus
decreas
estrogen
relat
increas
inflammatori
process
interestingli
hlf
express
endometrium
suggest
gestat
period
hlf
produc
uterin
epithelium
neutrophil
releas
cvf
control
sex
steroid
hormon
report
high
level
progesteron
parallel
low
level
estrogen
normal
pregnanc
ratio
invert
pregnant
women
preterm
deliveri
threat
determin
exist
regulatori
circuit
link
hlf
synthesi
sex
steroid
hormon
fluctuat
may
unravel
novel
mechan
lead
preterm
birth
lactobacillu
spp
lf
pivot
compon
firstlin
defens
femal
mucos
genit
tract
involv
protect
multitud
microbi
infect
effect
natur
mechan
dampen
inflammatori
process
inhibit
cervicovagin
infect
ideal
drug
inhibit
microbi
growth
microbi
adhes
entri
host
cell
microbi
intracellular
replic
andinfect
new
host
cell
microb
extracellularli
releas
infect
cell
vagin
environ
women
childbear
age
inhibit
bacteri
multipl
synthesi
antibacteri
substanc
lactobacilli
competit
microb
lf
iron
acquisit
repres
effect
natur
defens
mechan
lactobacilli
lf
inhibit
adhes
consequ
microbi
entri
insid
cell
interact
cell
surfac
compon
potenti
receptor
pathogen
lactobacilli
lf
appear
complementari
sinc
lactobacilli
inhibit
microbi
intracellular
replic
togeth
lf
hinder
infect
still
healthi
cell
microb
extracellularli
releas
close
cooper
also
exert
antiinflammatori
function
scenario
mucos
environ
repres
good
model
mutual
reciproc
injuri
microb
schemat
represent
lactobacillu
spp
lf
balanc
protect
pathogen
maintain
immun
homeostasi
vagin
tract
shown
figur
consid
shortag
effect
treatment
counteract
antibioticresist
bacteri
infect
intravagin
administr
lactobacilli
lf
could
novel
effici
therapeut
strategi
valuabl
tool
restor
mucos
immun
homeostasi
pm
rp
pv
conceiv
topic
concept
wrote
revis
final
manuscript
lr
ac
ml
dc
es
provid
figur
contribut
manuscript
prepar
edit
author
read
approv
final
version
author
declar
research
conduct
absenc
commerci
financi
relat
hip
could
constru
potenti
conflict
interest
